These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12387480)

  • 1. Effect of IVIgG treatment on fetal platelet count, HPA-1a titre and clinical outcome in a case of feto-maternal alloimmune thrombocytopenia.
    Lucas GF; Hamon M; Carroll S; Soothill P
    BJOG; 2002 Oct; 109(10):1195-8. PubMed ID: 12387480
    [No Abstract]   [Full Text] [Related]  

  • 2. Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT.
    Kaplan C; Murphy MF; Kroll H; Waters AH
    Br J Haematol; 1998 Jan; 100(1):62-5. PubMed ID: 9450792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies.
    Murphy MF; Waters AH; Doughty HA; Hambley H; Mibashan RS; Nicolaides K; Rodeck CH
    Transfus Med; 1994 Dec; 4(4):281-92. PubMed ID: 7889140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal management of fetuses with alloimmune thrombocytopenia].
    Kroll H; Kiefel V; Giers G; Kaplan C; Murphy M; Waters A; Mueller-Eckhardt C
    Beitr Infusionsther Transfusionsmed; 1996; 33():150-5. PubMed ID: 8974688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis.
    Spencer JA; Burrows RF
    Aust N Z J Obstet Gynaecol; 2001 Feb; 41(1):45-55. PubMed ID: 11284646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia.
    Sainio S; Teramo K; Kekomäki R
    Transfus Med; 1999 Dec; 9(4):321-30. PubMed ID: 10583886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with intravenous immunoglobulin G (ivIgG) during pregnancy for fetal alloimmune (HPA-1a(Zwa)) thrombocytopenic purpura.
    Giers G; Hoch J; Bauer H; Bald R; Kiefel V; Kroll H; Hansmann M; Hanfland P; Mueller-Eckhardt C; Scharf RE
    Prenat Diagn; 1996 Jun; 16(6):495-502. PubMed ID: 8809890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal alloimmune thrombocytopenia: antenatal management.
    Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR
    Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental diagnosis and tempestive therapy in a case of neonatal alloimmune thrombocytopenia due to anti-HPA-5b.
    Zuppa AA; Cota F; De Luca D; Visintini F; De Turris PL; Tortorolo G
    Pediatr Hematol Oncol; 2002 Dec; 19(8):587-91. PubMed ID: 12487835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prenatal substitution therapy in fetal alloimmune thrombocytopenia].
    Giers G; Hoch J; Bald R; Fischer J; Kroll H; Kiefel V; Scharf RE; Hanfland P; Hansmann M; Mueller-Eckhardt C
    Beitr Infusionsther Transfusionsmed; 1994; 32():453-8. PubMed ID: 9480142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of feto-maternal alloimmune thrombocytopenia: report of three cases.
    Paternoster DM; Cester M; Memmo A; Scandellari R; Fabris F; Girolami A
    J Matern Fetal Neonatal Med; 2006 Aug; 19(8):517-20. PubMed ID: 16966118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IVIgG and steroids.
    Summerfield GP; Beeby A; Bosman D; Chapman C
    Br J Haematol; 1998 Sep; 102(5):1380-1. PubMed ID: 9753075
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenatal management of fetal alloimmune thrombocytopenia.
    Vox Sang; 1993; 65(3):180-9. PubMed ID: 8249359
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility.
    Gaddipati S; Berkowitz RL; Lembet AA; Lapinski R; McFarland JG; Bussel JB
    Am J Obstet Gynecol; 2001 Oct; 185(4):976-80. PubMed ID: 11641688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal management of fetal alloimmune and autoimmune thrombocytopenia.
    Bussel JB; McFarland JG; Berkowitz RL
    Transfus Med Rev; 1990 Apr; 4(2):149-62. PubMed ID: 2134623
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal alloimmune thrombocytopenia due to anti-P1A1 (anti-HPA-1a): importance of paternal and fetal platelet typing for assessment of fetal risk.
    Lipitz S; Ryan G; Murphy MF; Robson SC; Haeusler MC; Metcalfe P; Kelsey H; Rodeck CH
    Prenat Diagn; 1992 Nov; 12(11):955-8. PubMed ID: 1494549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal interventions for fetomaternal alloimmune thrombocytopenia.
    Rayment R; Brunskill SJ; Stanworth S; Soothill PW; Roberts DJ; Murphy MF
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004226. PubMed ID: 15674934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia.
    Birchall JE; Murphy MF; Kaplan C; Kroll H;
    Br J Haematol; 2003 Jul; 122(2):275-88. PubMed ID: 12846898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia.
    Ghevaert C; Campbell K; Walton J; Smith GA; Allen D; Williamson LM; Ouwehand WH; Ranasinghe E
    Transfusion; 2007 May; 47(5):901-10. PubMed ID: 17465957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.